Healthpeak Properties, Inc. (DOC)
NYSE: DOC · Real-Time Price · USD
17.02
-0.16 (-0.93%)
At close: Dec 5, 2025, 4:00 PM EST
17.07
+0.05 (0.29%)
After-hours: Dec 5, 2025, 7:50 PM EST
Healthpeak Properties Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Healthpeak Properties stock have an average target of 20.3, with a low estimate of 18 and a high estimate of 25. The average target predicts an increase of 19.27% from the current stock price of 17.02.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Healthpeak Properties stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 5 | 6 | 7 | 6 | 5 | 4 |
| Hold | 3 | 4 | 4 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 12 | 12 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | +11.63% | Nov 25, 2025 |
| Baird | Baird | Buy Maintains $21 → $20 | Buy | Maintains | $21 → $20 | +17.51% | Nov 12, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $20 | Hold | Initiates | $20 | +17.51% | Oct 1, 2025 |
| Raymond James | Raymond James | Hold → Buy Upgrades $20 | Hold → Buy | Upgrades | $20 | +17.51% | Sep 15, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $20 → $18 | Hold | Maintains | $20 → $18 | +5.76% | Aug 27, 2025 |
Financial Forecast
Revenue This Year
2.80B
from 2.70B
Increased by 3.50%
Revenue Next Year
2.86B
from 2.80B
Increased by 2.25%
EPS This Year
0.23
from 0.36
Decreased by -35.62%
EPS Next Year
0.27
from 0.23
Increased by 15.69%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.0B | 3.1B | ||||
| Avg | 2.8B | 2.9B | ||||
| Low | 2.7B | 2.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.0% | 11.3% | ||||
| Avg | 3.5% | 2.3% | ||||
| Low | -0.8% | -2.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 0.25 | 0.35 | ||||
| Avg | 0.23 | 0.27 | ||||
| Low | 0.20 | 0.16 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -29.7% | 50.1% | ||||
| Avg | -35.6% | 15.7% | ||||
| Low | -45.3% | -32.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.